Atlas Trials

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Clinical trial NCT00745771 · COMPLETED

Trial details

NCT number
NCT00745771
Sponsor
IDEA AG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Muscle Soreness
Start date
2007-10-01
Primary completion
2008-02-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.